FREQUENCY OF OBESITY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AT LADY READING HOSPITAL, PESHAWAR

H ANWAR; I ULLAH

doi:10.54112/pjicm.v5i02.137

Authors

H ANWAR Department of Medicine, Lady Reading Hospital, Peshawar, Pakistan
I ULLAH Department of Medicine, Lady Reading Hospital, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/pjicm.v5i02.137

Keywords:

Type 2 DIABETES MELLITUS, OBESITY, DYSLIPIDEMIA, GLYCEMIC CONTROL, HYPERTENSION

Abstract

Background: Obesity is a significant public health concern and a well-recognized risk factor for the development and progression of type 2 diabetes mellitus (T2DM). Assessing the prevalence of obesity among T2DM patients is essential for effective disease management and prevention of complications. Objective: To determine the frequency of obesity in patients with T2DM presenting to Lady Reading Hospital, Peshawar. Study Design: Cross-sectional study. Setting: Department of Medicine, Lady Reading Hospital, Peshawar. Duration of Study: 04-October-2024 to 04-April-2025. Methods: A total of 119 patients with T2DM, aged 18–70 years, were enrolled using consecutive sampling. Obesity was defined as body mass index (BMI) ≥30 kg/m². Anthropometric measurements and relevant laboratory investigations were performed for all participants. Data were analyzed using descriptive statistics, with frequencies and percentages for categorical variables and mean ± standard deviation (SD) for continuous variables. Results: The mean age of participants was 50.25 ± 14.33 years. Of these, 57 (47.9%) were males and 62 (52.1%) were females. The prevalence of obesity was observed in 48 (40.3%) patients. The mean BMI was 28.58 ± 3.25. Hypertension was present in 69 (58.0%) patients, and 18 (15.1%) were smokers. Conclusion: Obesity was prevalent in 40.3% of T2DM patients in our study, highlighting the need for targeted interventions focusing on lifestyle modification and weight management to improve diabetes outcomes.

References

Zhou B, Rayner AW, Gregg EW, Sheffer KE, Carrillo-Larco RM, Bennett JE, et al. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024;404(10467):2077–93. https://doi.org/10.1016/S0140-6736(24)02317-1

Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–34. https://doi.org/10.1016/S0140-6736(23)01301-6

Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. https://doi.org/10.1186/1478-7954-8-29

Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80. https://doi.org/10.1016/S2213-8587(17)30186-9

Abel ED, Gloyn AL, Evans-Molina C, Joseph JJ, Misra S, Pajvani UB, et al. Diabetes mellitus—Progress and opportunities in the evolving epidemic. Cell. 2024;187(15):3789–820. https://doi.org/10.1016/j.cell.2024.06.029

Strati M, Moustaki M, Psaltopoulou T, Vryonidou A, Paschou SA. Early onset type 2 diabetes mellitus: an update. Endocrine. 2024;85(3):965–78.

https://doi.org/10.1007/s12020-024-03772-w

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275. https://doi.org/10.3390/ijms21176275

Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol. 2021;17(9):534–48. https://doi.org/10.1038/s41574-021-00512-2

Saalbach A, Anderegg U. Thy-1: more than a marker for mesenchymal stromal cells. FASEB J. 2019;33(6):6689–96. https://doi.org/10.1096/fj.201802224R

Kozlov AI. [Carbohydrate-related nutritional and genetic risks of obesity for indigenous northerners]. Vopr Pitan. 2019;88(1):5–16. Russian. https://doi.org/10.24411/0042-8833-2019-10001

Gowd V, Xie L, Zheng X, Chen W. Dietary fibers as emerging nutritional factors against diabetes: focus on the involvement of gut microbiota. Crit Rev Biotechnol. 2019;39(4):524–40. https://doi.org/10.1080/07388551.2019.1576025

Holly JMP, Biernacka K, Perks CM. Systemic metabolism, its regulators, and cancer: past mistakes and future potential. Front Endocrinol (Lausanne). 2019;10:65. https://doi.org/10.3389/fendo.2019.00065.

Akinkuotu AC, Hamilton JK, Birken C, Toulany A, Strom M, Noseworthy R, et al. Evolution and outcomes of a Canadian pediatric bariatric surgery program. J Pediatr Surg. 2019;54(5):1049–53. https://doi.org/10.1016/j.jpedsurg.2018.06.019

Chen GC, Arthur R, Iyengar NM, Kamensky V, Xue X, Wassertheil-Smoller S, et al. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019;40(34):2849–55. https://doi.org/10.1093/eurheartj/ehz343

Sparrow D, Borkan GA, Gerzof SG, Wisniewski C, Silbert CK. Relationship of fat distribution to glucose tolerance: results of computed tomography in male participants of the Normative Aging Study. Diabetes. 1986;35(4):411–5. https://doi.org/10.2337/diab.35.4.411

Tino S, Mayanja BN, Mubiru MC, Eling E, Ddumba E, Kaleebu P, et al. Prevalence and factors associated with overweight and obesity among patients with type 2 diabetes mellitus in Uganda—a descriptive retrospective study. BMJ Open. 2020;10(11):e039258. https://doi.org/10.1136/bmjopen-2020-039258

Ahmed N, Ahmad T, Hussain SJ, Javed M. Frequency of metabolic syndrome in patients with type-2 diabetes. J Ayub Med Coll Abbottabad. 2010;22(1):139–42.

Alawainati MA, Ayoob ZA, AlQari AA, Makhlooq F, Naser HS, Bukamal F. Prevalence and characteristics of obesity in patients with type-2 diabetes mellitus in primary care centers in Bahrain: a cross-sectional study. J Fam Community Med. 2023;30(2):109–15. https://doi.org/10.4103/jfcm.jfcm_9_23

Khan S, Ubaid M, Wazir Z, Khan S, Khan IA. Frequency of obesity in patients with type 2 diabetes mellitus. J Med Sci. 2024;32(2):126–30. https://doi.org/10.52764/jms.24.32.2.2

Zeb F, Pervez S, Kaleemullah M, Wahab A, Khan B, Salih N. Frequency of obesity in type II diabetes mellitus patients. Med Forum. 2023;34(4):70–72. medicalforummonthly.com

Mugharbel KM, Al-Mansouri MA. Prevalence of obesity among type 2 diabetic patients in Al-Khobar primary health care centers. J Fam Community Med. 2003;10(2):49–53.